Mirae Asset Global Investments’s Verve Therapeutics VERV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $38.7K | Buy |
3,444
+473
| +16% | +$5.31K | ﹤0.01% | 1298 |
|
2025
Q1 | $15.5K | Buy |
2,971
+150
| +5% | +$783 | ﹤0.01% | 1416 |
|
2024
Q4 | $17K | Sell |
2,821
-240
| -8% | -$1.45K | ﹤0.01% | 1442 |
|
2024
Q3 | $15.2K | Buy |
3,061
+554
| +22% | +$2.76K | ﹤0.01% | 1467 |
|
2024
Q2 | $11.9K | Sell |
2,507
-169,288
| -99% | -$806K | ﹤0.01% | 1444 |
|
2024
Q1 | $2.45M | Buy |
171,795
+59,034
| +52% | +$841K | 0.01% | 1099 |
|
2023
Q4 | $1.57M | Sell |
112,761
-99,343
| -47% | -$1.38M | ﹤0.01% | 1376 |
|
2023
Q3 | $2.81M | Buy |
212,104
+17,277
| +9% | +$229K | 0.01% | 1050 |
|
2023
Q2 | $3.65M | Buy |
194,827
+25,881
| +15% | +$485K | 0.01% | 982 |
|
2023
Q1 | $2.44M | Buy |
168,946
+12,165
| +8% | +$175K | 0.01% | 1116 |
|
2022
Q4 | $3.03M | Buy |
156,781
+19,982
| +15% | +$387K | 0.01% | 973 |
|
2022
Q3 | $4.7M | Buy |
136,799
+19,101
| +16% | +$656K | 0.01% | 822 |
|
2022
Q2 | $1.8M | Buy |
+117,698
| New | +$1.8M | ﹤0.01% | 1173 |
|